ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

Recognized by their peers, applauded by the world: VHIO’s Josep Tabernero and Enriqueta Felip among Clarivate’s 6,167 Global Highly Cited Researchers 2020

18/11/2020|Comments Off on Recognized by their peers, applauded by the world: VHIO’s Josep Tabernero and Enriqueta Felip among Clarivate’s 6,167 Global Highly Cited Researchers 2020

Strengthening cancer control & prevention: ESMO and IACR co-launch the World Cancer Report’s e-learning platform

17/11/2020|Comments Off on Strengthening cancer control & prevention: ESMO and IACR co-launch the World Cancer Report’s e-learning platform

Countdown to World Cancer Day 04 February: the 21 Days to Impact Challenge

11/11/2020|Comments Off on Countdown to World Cancer Day 04 February: the 21 Days to Impact Challenge

Movember movement against prostate cancer: much more than moustaches

29/10/2020|Comments Off on Movember movement against prostate cancer: much more than moustaches

VHIO in 2019: tick tock toward 2025

28/10/2020|Comments Off on VHIO in 2019: tick tock toward 2025

Cerebrospinal fluid as liquid biopsy for the precise characterization and policing of medulloblastoma

27/10/2020|Comments Off on Cerebrospinal fluid as liquid biopsy for the precise characterization and policing of medulloblastoma

SEE ALL NEWS

Follow us:

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO’s Scientific Committee. A total of 26 renowned Principal Investigators manage and run VHIO’s major research themes and programs.

BROWSE OUR PIS

SCIENTIFIC
REPORT
2019

LAUNCH

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER (UITM) – “LA CAIXA” FOUNDATION
CURRENTLY OPEN TRIALS

PROJECTS & INSTITUTIONAL PROGRAMS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
FERO FOUNDATION’S ADVANCED MOLECULAR DIAGNOSTICS PROGRAM
BBVA FOUNDATION’S IMMUNOTHERAPY & IMMUNOLOGY PROGRAM (CAIMI)
“LA CAIXA” INTL RESEARCH & EDUCATION PROGRAM
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

VHIO – ”LA CAIXA” SCIENTIFIC SEMINARS SERIES
INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS